While sterilizing immunity against HIV-1 infection requires a strong humoral response including neutralizing antibodies, lessons from preclinical studies have shown that CD8+ and CD4+ T cell responses are important in facilitating both the humoral and cell-mediated immunity induced by an HIV-1 vaccine. The gene discussed is CD8A; the disease is HIV-1 infection.